Cision PR Newswire

Abu Dhabi Health Delegation Concludes Inaugural Visit to China, Opening New Pathways to Advance AI, Precision Medicine and Next-Gen Therapies

ABU DHABI, UAE, Oct. 18, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has...

China Mobile Hong Kong Establishes Hong Kong’s First U6G Network

Expanding Next-Generation Network Capabilities and Accelerating the Innovative Convergence of Communication, Computing, and AI...

AGFUND wins international award for excellence in inclusive banking and social impact

 Prince Abdulaziz bin Talal credits the founders of AGFUND's microfinance banks for laying the...

JinkoSolar Unveils Tiger Neo 5.0 All-Black Residential Solar Module with 25.52% Efficiency

SHANGRAO, China, Oct. 17, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the...

GAC Showcases Multiple Models at Canton Fair: Systemic Global Expansion as a Response to High‑Level Opening‑Up

GUANGZHOU, China, Oct. 17, 2026 /PRNewswire/ -- On 15 October, the 140th China Import...

/DISREGARD RELEASE: Ample/

We are advised by Ample that journalists and other readers should disregard the news release, Visa Partners with Ample Earth to Power Sustainable Spending,...

US Food and Drug Administration (FDA) Approves Henlius and Organon’s BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

SHANGHAI and JERSEY CITY, N.J., Sept. 2, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the US Food and Drug...

Beetles Gel Polish’s Limited-Edition Halloween Gift Box “Scream on Halloween” Makes Its Spooky Debut

NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Halloween is more than just trick-or-treating. It's a tradition that lets you bring out your personality and...